Literature DB >> 29748181

Clonal Hematopoiesis: A New Layer in the Liquid Biopsy Story in Lung Cancer.

Joshua Bauml1, Benjamin Levy2.   

Abstract

Cell-free DNA (cfDNA) is a unique biospecimen that contains multiple sources of DNA, including tumor, germline, fetal, and others. Clonal hematopoiesis, a process that leads to expansion of mutations in peripheral blood cells, is an additional source of DNA that adds a layer of complexity when interpreting results. Clin Cancer Res; 24(18); 4352-4. ©2018 AACRSee related article by Hu et al., p. 4437. ©2018 American Association for Cancer Research.

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29748181     DOI： 10.1158/1078-0432.CCR-18-0969

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


  14 in total

1.  Impact of KRAS and TP53 Co-Mutations on Outcomes After First-Line Systemic Therapy Among Patients With STK11-Mutated Advanced Non-Small-Cell Lung Cancer.

Authors:  Erin Bange; Melina E Marmarelis; Wei-Ting Hwang; Yu-Xiao Yang; Jeffrey C Thompson; Jason Rosenbaum; Joshua M Bauml; Christine Ciunci; Evan W Alley; Roger B Cohen; Corey J Langer; Erica Carpenter; Charu Aggarwal
Journal:  JCO Precis Oncol       Date:  2019-05-10

2.  Fragment Size Analysis May Distinguish Clonal Hematopoiesis from Tumor-Derived Mutations in Cell-Free DNA.

Authors:  Francesco Marass; Dennis Stephens; Ryan Ptashkin; Ahmet Zehir; Michael F Berger; David B Solit; Luis A Diaz; Dana W Y Tsui
Journal:  Clin Chem       Date:  2020-04-01       Impact factor: 8.327

Review 3.  Clinical applications of liquid biopsies for early lung cancer detection.

Authors:  Hao Zheng; Xin Wu; Jie Yin; Shuang Wang; Zhi Li; Changxuan You
Journal:  Am J Cancer Res       Date:  2019-12-01       Impact factor: 6.166

4.  Using All Our Genomes: Blood-based Liquid Biopsies for the Early Detection of Cancer.

Authors:  Eddie Adams; Gregory D Sepich-Poore; Sandrine Miller-Montgomery; Rob Knight
Journal:  View (Beijing)       Date:  2022-01-31

5.  Liquid biopsy in gliomas: A RANO review and proposals for clinical applications.

Authors:  Riccardo Soffietti; Chetan Bettegowda; Ingo K Mellinghoff; Katherine E Warren; Manmeet S Ahluwalia; John F De Groot; Evanthia Galanis; Mark R Gilbert; Kurt A Jaeckle; Emilie Le Rhun; Roberta Rudà; Joan Seoane; Niklas Thon; Yoshie Umemura; Michael Weller; Martin J van den Bent; Michael A Vogelbaum; Susan M Chang; Patrick Y Wen
Journal:  Neuro Oncol       Date:  2022-06-01       Impact factor: 13.029

Review 6.  Next-Generation Sequencing with Liquid Biopsies from Treatment-Naïve Non-Small Cell Lung Carcinoma Patients.

Authors:  Paul Hofman
Journal:  Cancers (Basel)       Date:  2021-04-23       Impact factor: 6.639

7.  Clinical significance of clonal hematopoiesis in the interpretation of blood liquid biopsy.

Authors:  Hiu Ting Chan; Satoshi Nagayama; Yoon Ming Chin; Masumi Otaki; Rie Hayashi; Kazuma Kiyotani; Yosuke Fukunaga; Masashi Ueno; Yusuke Nakamura; Siew-Kee Low
Journal:  Mol Oncol       Date:  2020-06-08       Impact factor: 6.603

8.  Genome-wide cell-free DNA mutational integration enables ultra-sensitive cancer monitoring.

Authors:  Asaf Zviran; Rafael C Schulman; Minita Shah; Steven T K Hill; Sunil Deochand; Cole C Khamnei; Dillon Maloney; Kristofer Patel; Will Liao; Adam J Widman; Phillip Wong; Margaret K Callahan; Gavin Ha; Sarah Reed; Denisse Rotem; Dennie Frederick; Tatyana Sharova; Benchun Miao; Tommy Kim; Greg Gydush; Justin Rhoades; Kevin Y Huang; Nathaniel D Omans; Patrick O Bolan; Andrew H Lipsky; Chelston Ang; Murtaza Malbari; Catherine F Spinelli; Selena Kazancioglu; Alexi M Runnels; Samantha Fennessey; Christian Stolte; Federico Gaiti; Giorgio G Inghirami; Viktor Adalsteinsson; Brian Houck-Loomis; Jennifer Ishii; Jedd D Wolchok; Genevieve Boland; Nicolas Robine; Nasser K Altorki; Dan A Landau
Journal:  Nat Med       Date:  2020-06-01       Impact factor: 53.440

9.  Preferred end coordinates and somatic variants as signatures of circulating tumor DNA associated with hepatocellular carcinoma.

Authors:  Peiyong Jiang; Kun Sun; Yu K Tong; Suk Hang Cheng; Timothy H T Cheng; Macy M S Heung; John Wong; Vincent W S Wong; Henry L Y Chan; K C Allen Chan; Y M Dennis Lo; Rossa W K Chiu
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-29       Impact factor: 11.205

10.  Ultradeep targeted sequencing of circulating tumor DNA in plasma of early and advanced breast cancer.

Authors:  Yoon Ming Chin; Yoko Takahashi; Hiu Ting Chan; Masumi Otaki; Makoto Fujishima; Tomoko Shibayama; Yoshio Miki; Takayuki Ueno; Yusuke Nakamura; Siew-Kee Low
Journal:  Cancer Sci       Date:  2020-11-04       Impact factor: 6.518
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.